In general, N-terminally truncated Aβ species like Aβ2-x, Aβ3-x and Aβ4-x are derived by APP processing and are elevated in brains of AD patients with an increased aggregation propensity compared with Aβ1-x peptides [72, 88–90]. The gene discussed is APP; the disease is Alzheimer disease.